1.6600
24-February-25 15:50:28
15 minutes delayed
Stocks
-0.1000
-5.68%
Today's range
1.6600 - 1.8600
ISIN
N/A
Source
NASDAQ
PharmaCyte Biotech Board of Directors Announces Business Review Committee to Evaluate Opportunities to Optimize Shareholder Value
07 Oct 2022 09:00:00 By Nasdaq GlobeNewswire